52 related articles for article (PubMed ID: 15781267)
1. Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia.
Hamanaka Y; Mukai M; Shimamura M; Kitagawa T; Nishida T; Isohashi F; Ito T; Nishizawa Y; Tatsuta M; Matsuda H; Inoue M
Biochem Biophys Res Commun; 2005 Apr; 330(1):318-26. PubMed ID: 15781267
[TBL] [Abstract][Full Text] [Related]
2. Activation of insulin-like growth factor signaling induces apoptotic cell death under prolonged hypoxia by enhancing endoplasmic reticulum stress response.
Endo H; Murata K; Mukai M; Ishikawa O; Inoue M
Cancer Res; 2007 Sep; 67(17):8095-103. PubMed ID: 17804721
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
Kaper F; Dornhoefer N; Giaccia AJ
Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
[TBL] [Abstract][Full Text] [Related]
4. A potential mechanism for short time exposure to hypoxia-induced DNA synthesis in primary cultured chicken hepatocytes: Correlation between Ca(2+)/PKC/MAPKs and PI3K/Akt/mTOR.
Lee SH; Lee MY; Lee JH; Han HJ
J Cell Biochem; 2008 Aug; 104(5):1598-611. PubMed ID: 18646054
[TBL] [Abstract][Full Text] [Related]
5. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
Xu Y; Chen SY; Ross KN; Balk SP
Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
[TBL] [Abstract][Full Text] [Related]
6. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
[TBL] [Abstract][Full Text] [Related]
8. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.
Knaup KX; Jozefowski K; Schmidt R; Bernhardt WM; Weidemann A; Juergensen JS; Warnecke C; Eckardt KU; Wiesener MS
Mol Cancer Res; 2009 Jan; 7(1):88-98. PubMed ID: 19147540
[TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
[TBL] [Abstract][Full Text] [Related]
10. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.
Anderson KM; Jajeh J; Guinan P; Rubenstein M
Anticancer Res; 2009 Nov; 29(11):4579-88. PubMed ID: 20032407
[TBL] [Abstract][Full Text] [Related]
12. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
Jiang W; Zhu Z; Thompson HJ
Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
[TBL] [Abstract][Full Text] [Related]
14. In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism.
Pellegatta F; Catapano AL; Luzi L; Terruzzi I
J Cardiovasc Pharmacol; 2006 May; 47(5):643-9. PubMed ID: 16775502
[TBL] [Abstract][Full Text] [Related]
15. Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway.
Chenal J; Pellerin L
J Neurochem; 2007 Jul; 102(2):389-97. PubMed ID: 17394554
[TBL] [Abstract][Full Text] [Related]
16. The effects of amino acids on glucose metabolism of isolated rat skeletal muscle are independent of insulin and the mTOR/S6K pathway.
Stadlbauer K; Brunmair B; Szöcs Z; Krebs M; Luger A; Fürnsinn C
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E785-92. PubMed ID: 19622787
[TBL] [Abstract][Full Text] [Related]
17. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages.
Yang CS; Song CH; Lee JS; Jung SB; Oh JH; Park J; Kim HJ; Park JK; Paik TH; Jo EK
Cell Microbiol; 2006 Jul; 8(7):1158-71. PubMed ID: 16819968
[TBL] [Abstract][Full Text] [Related]
18. Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors.
Rotin D; Robinson B; Tannock IF
Cancer Res; 1986 Jun; 46(6):2821-6. PubMed ID: 3698008
[TBL] [Abstract][Full Text] [Related]
19. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
Mungamuri SK; Yang X; Thor AD; Somasundaram K
Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424
[TBL] [Abstract][Full Text] [Related]
20. Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth.
Jossin Y; Goffinet AM
Mol Cell Biol; 2007 Oct; 27(20):7113-24. PubMed ID: 17698586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
